Stevia Corp.'s Subsidiary Completes Successful Extraction of Cannabidiol (CBD) From Industrial Hemp in Laboratory
May 07 2014 - 7:45AM
Marketwired
Stevia Corp.'s Subsidiary Completes Successful Extraction of
Cannabidiol (CBD) From Industrial Hemp in Laboratory
Company to Pursue Growing Market Opportunity for Commercial
Supplies of CBD and Also Intends to Launch Dietary Supplements Rich
in CBD
INDIANAPOLIS, IN--(Marketwired - May 7, 2014) - Stevia Corp.
(OTCQB: STEV) ("Stevia Corp" or the "Company"), an international
farm management company focused on the economic development of
products that support a healthy lifestyle, including stevia and
hemp, is pleased to announce the Company's Hong Kong subsidiary,
Stevia Technew Ltd, has successfully extracted cannabidiol (CBD)
from industrial hemp grown in China where 70% of the world's hemp
supply is grown. Leveraging the Company's experience extracting and
refining steviol glycosides from the stevia plant, Stevia Technew
intends to work with local partners to transition CBD extraction
from laboratory to commercial scale production.
CBD is one of at least 85 cannabinoids (chemical compounds found
in both industrial hemp and marijuana) and is the major constituent
in industrial hemp plants. Hundreds of scientific studies have
demonstrated CBD's potential in addressing a wide range of serious
conditions, including rheumatoid arthritis, diabetes, chronic pain,
schizophrenia, PTSD, epilepsy, Alzheimer's, Parkinson's, HIV
dementia and many others. CBD is also non-psychoactive and avoids
toxicity that is encountered with psychoactive cannabinoids at high
doses.
CBD's promising potential has been the subject of intense media
publicity in recent months including the documentary special "WEED"
by CNN chief medical correspondent Dr. Sanjay Gupta who spent a
year traveling around the world to shed light on the debate of
medical marijuana. One of many cases highlighted by Dr. Gupta was
Charlotte Figi, a young child who suffered from Dravet Syndrome, a
rare and severe form of intractable epilepsy that strikes young
children and is not controllable with traditional medication but
responded to treatment with an extract from medical marijuana that
was high in CBD and low in THC (the psychoactive cannabinoid) with
no apparent side effects.
The Oil extracted from industrial hemp contains almost no THC
and is well below the US legal threshold of 0.3% for hemp products
to be sold in the US where the annual retail value of hemp products
is more than $500 million. Once CBD is extracted from industrial
hemp, it lends itself as a dietary supplement which can be consumed
in many forms including oil droplets, CBD infused gum, and soft-gel
tablets.
George Blankenbaker, Stevia Corp President, commented, "It is
still illegal to grow industrial hemp in the US for commercial
purposes so our Hong Kong subsidiary will continue leveraging its
relationships in Asia where the China government is targeting to
increase production of hemp to more than 3 million acres and is
developing advanced technologies for the commercialization of hemp
products. Working with its partners in Asia, our subsidiary has
access to the largest source of hemp with the ability to breed even
more efficient varieties while leveraging existing extraction
facilities."
Further details of the Company's business, finances,
appointments and agreements can be found as part of the Company's
continuous public disclosure as a reporting issuer under the
Securities Exchange Act of 1934, as amended, filed with the
Securities and Exchange Commission's ("SEC") EDGAR database. For
more information visit: www.steviacorp.us.
About Stevia Corp. (OTCQB: STEV) Stevia Corp. is a farm
management company focused on developing highly nutritional, high
value products through proprietary plant breeding, excellent
agricultural methodologies and innovative post-harvest techniques.
Stevia Corp invests in R&D and IP acquisition and manages its
own propagation, nursery and plantations as well as provides
services to contract growers and other industry growers. Stevia
Corp was founded on the principal of implementing socially
responsible, sustainable, quality agribusiness solutions to
maximize the long-term efficient production of nutritional crops.
For additional information please visit: www.steviacorp.us.
About the Hemp Industry Sector Hemp is a crop that can be grown
for food and non-food purposes. As a result of its numerous
nutritional benefits, many new food products containing hemp seed
and its oil are finding their way into the marketplace, including
pasta, tortilla chips, salad dressings, snack products and frozen
desserts. Non-dairy hemp "milk" beverages, which provide
significant amounts of omega 3 essential fatty acids (EFAs) and
protein, are also available. Hemp oil is also used in
nutraceuticals and health care products.
As a fiber source, hemp is undergoing rapid growth as a natural
fiber in everything from clothing and textiles to automotive
composites. The fiber is also gaining popularity as insulation.
The Hemp Industries Association (HIA) estimated that the retail
value of North American hemp food, vitamin and body care products
was in the range of $156 to $171 million in 2012. When clothing,
auto parts, building materials and other non-food or body care
products are included, the HIA estimates that the total retail
value of U.S. hemp products is about $500 million.
Food and fiber uses for industrial hemp are growing rapidly and
have increased over 300 percent, to an estimated 25,000 products,
in the past few years. Much of that growth is coming from the
increased sales of hemp food products.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that
term is defined in Section 27A of the United States Securities Act
of 1933, as amended and Section 21E of the Securities Exchange Act
of 1934, as amended. Statements in this press release which are not
purely historical are forward-looking statements and include any
statements regarding beliefs, plans, expectations or intentions
regarding the future. Such forward-looking statements include,
among other things, transition cannabidiol extraction from
laboratory to commercial scale production, annual retail value of
hemp products sold in the U.S., developing hemp products, growth of
industrial hemp product industry, product development and business
strategy. Actual results could differ from those projected in any
forward-looking statements due to numerous factors. Such factors
include, among others, the inherent uncertainties associated with
new projects and development stage companies. These forward-looking
statements are made as of the date of this news release, and we
assume no obligation to update the forward-looking statements, or
to update the reasons why actual results could differ from those
projected in the forward-looking statements. Although we believe
that any beliefs, plans, expectations and intentions contained in
this press release are reasonable, there can be no assurance that
any such beliefs, plans, expectations or intentions will prove to
be accurate. Investors should consult all of the information set
forth herein and should also refer to the risk factors disclosure
outlined in our annual report on Form 10-K for the most recent
fiscal year, our quarterly reports on Form 10-Q and other periodic
reports filed from time-to-time with the Securities and Exchange
Commission.
Contact: Stevia Corp. Investor Relations Email: ir@stevia.co
Tel: +1-888-250-2566 Web: www.steviacorp.us
Stevia (PK) (USOTC:STEV)
Historical Stock Chart
From Feb 2025 to Mar 2025
Stevia (PK) (USOTC:STEV)
Historical Stock Chart
From Mar 2024 to Mar 2025